Investigational Site Number : 2500001

Nantes 44093

2 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Chronic Rhinosinusitis With Nasal Polyps, Malignant Melanoma, Multiple Myeloma, Plasma Cell Myeloma, Plasma Cell Myeloma Refractory, Prurigo Nodularis, Relapsing Multiple Sclerosis, Squamous Cell Carcinoma of Skin

Studies at this site

• Isatuximab in Combination With Novel Agents in RRMM - Master Protocol — Recruiting now
• A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma — Recruiting now
• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
• A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) — Stopped early
• Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer — Stopped early
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed
• Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study — Running, not enrolling
• Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) — Completed